P2X7 receptor knockout does not alter renal function or prevent angiotensin II-induced kidney injury in F344 rats
Scientific Reports · 2024
DOI: 10.1038/s41598-024-59635-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Scientific Reports, 2024. Verfasst von Josselin Nespoux und 9 weiteren Autor:innen. Beteiligte Einrichtung: Edinburgh Kidney, British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, UK. Hauptthemen laut MEDLINE: Receptors, Purinergic P2X7, Angiotensin II, Kidney, Rats, Inbred F344. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: British Heart Foundation, Diabetes UK, PhD Studentship; The University of Edinburgh.
Abstract (Originalsprache)
P2X7 receptors mediate immune and endothelial cell responses to extracellular ATP. Acute pharmacological blockade increases renal blood flow and filtration rate, suggesting that receptor activation promotes tonic vasoconstriction. P2X7 expression is increased in kidney disease and blockade/knockout is renoprotective. We generated a P2X7 knockout rat on F344 background, hypothesising enhanced renal blood flow and protection from angiotensin-II-induced renal injury. CRISPR/Cas9 introduced an early stop codon into exon 2 of P2rx7 , abolishing P2X7 protein in kidney and reducing P2rx7 mRNA abundance by ~ 60% in bone-marrow derived macrophages. The M1 polarisation response to lipopolysaccharide was unaffected but P2X7 receptor knockout suppressed ATP-induced IL-1β release. In male knockout rats, acetylcholine-induced dilation of the renal artery ex vivo was diminished but not the response to nitroprusside. Renal function in male and female knockout rats was not different from wild-type. Finally, in male rats infused with angiotensin-II for 6 weeks, P2X7 knockout did not reduce albuminuria, tubular injury, renal macrophage accrual, and renal perivascular fibrosis. Contrary to our hypothesis, global P2X7 knockout had no impact on in vivo renal hemodynamics. Our study does not indicate a major role for P2X7 receptor activation in renal vascular injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Edinburgh Kidney, British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, UK.
- Edinburgh Kidney, British Heart Foundation Centre for Cardiovascular Science, The University of Edinburgh, Edinburgh, UK. Matthew.bailey@ed.ac.uk.
ORCID-Profile: Matthew A Bailey
Förderung
- British Heart Foundation
- Diabetes UK
- PhD Studentship; The University of Edinburgh
- Kidney Research UK
- RCUK | Medical Research Council
Zitieren
APA
Nespoux, J., Monaghan, M. T., Jones, N. K., Stewart, K., Denby, L., Czopek, A., Mullins, J. J., Menzies, R. I., Baker, A. H., & Bailey, M. A. (2024). P2X7 receptor knockout does not alter renal function or prevent angiotensin II-induced kidney injury in F344 rats. Scientific Reports. https://doi.org/10.1038/s41598-024-59635-x
Vancouver
Nespoux J, Monaghan MT, Jones NK, Stewart K, Denby L, Czopek A, et al. P2X7 receptor knockout does not alter renal function or prevent angiotensin II-induced kidney injury in F344 rats. Scientific Reports. 2024. doi:10.1038/s41598-024-59635-x
BibTeX
@article{Nespoux2024,
author = {Nespoux, Josselin and Monaghan, Marie-Louise T and Jones, Natalie K and Stewart, Kevin and Denby, Laura and Czopek, Alicja and Mullins, John J and Menzies, Robert I and Baker, Andrew H and Bailey, Matthew A},
title = {P2X7 receptor knockout does not alter renal function or prevent angiotensin II-induced kidney injury in F344 rats},
journal = {Scientific Reports},
year = {2024},
doi = {10.1038/s41598-024-59635-x}
}
EUVIMED